Filter News
Area of Research
- (-) Biology and Environment (132)
- Advanced Manufacturing (8)
- Biological Systems (1)
- Biology and Soft Matter (1)
- Building Technologies (2)
- Clean Energy (187)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (16)
- Electricity and Smart Grid (1)
- Energy Frontier Research Centers (1)
- Energy Sciences (2)
- Functional Materials for Energy (2)
- Fusion and Fission (12)
- Fusion Energy (4)
- Isotopes (11)
- Materials (164)
- Materials Characterization (2)
- Materials for Computing (23)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (28)
- Neutron Science (112)
- Nuclear Science and Technology (9)
- Quantum information Science (8)
- Supercomputing (137)
News Topics
- (-) Biomedical (16)
- (-) Clean Water (11)
- (-) Computer Science (19)
- (-) Energy Storage (7)
- (-) Environment (90)
- (-) Exascale Computing (4)
- (-) Materials (12)
- (-) Nanotechnology (7)
- (-) Neutron Science (4)
- (-) Sustainable Energy (30)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Artificial Intelligence (9)
- Big Data (10)
- Bioenergy (45)
- Biology (73)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Climate Change (41)
- Composites (5)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (9)
- Materials Science (6)
- Mathematics (4)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- National Security (3)
- Net Zero (2)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (15)
- Summit (10)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Researchers at Oak Ridge National Laboratory were part of an international team that collected a treasure trove of data measuring precipitation, air particles, cloud patterns and the exchange of energy between the atmosphere and the sea ice.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
New capabilities and equipment recently installed at the Department of Energy’s Oak Ridge National Laboratory are bringing a creek right into the lab to advance understanding of mercury pollution and accelerate solutions.
Popular wisdom holds tall, fast-growing trees are best for biomass, but new research by two U.S. Department of Energy national laboratories reveals that is only part of the equation.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight